No Baby Blisters, a 501(c)(3) nonprofit with a Platinum GuideStar transparency rating, has announced the expansion of its awareness and support campaign for Epidermolysis Bullosa (EB), a rare genetic disease affecting over 500,000 people worldwide. The expanded initiative provides immediate life-saving supplies to medically neglected children while simultaneously funding research toward a potential full-body cure. Dr. Aaron Tabor, MD, founder of No Baby Blisters, a Johns Hopkins School of Medicine alumnus, and an NIH-funded skin researcher who also serves as Founder and CEO of GENIEXO, established the organization after identifying a critical gap in care for children suffering from EB and other terminal diseases in regions without access to healthcare.
More information is available at https://nobabyblisters.org/updates/
EB represents a significant yet historically underfunded orphan disease, a classification applied to conditions affecting fewer than 200,000 people nationwide according to the National Institutes of Health. In its most severe forms, many babies born with EB do not survive their first year. Those who do often face a life expectancy of less than 30 years, filled with chronic pain, infections, scarring, and repeated hospitalizations, explains No Baby Blisters. Major pharmaceutical companies and governments have historically neglected orphan diseases like EB, creating a funding gap that leaves children in poverty without access to medical supplies or treatment options.
The organization provides direct-aid interventions documented through case studies, including Baby John. Donations fund advanced bandages, pain medicine, antibiotics, ointments, and nutrition support that address the immediate needs of children whose skin blisters and peels away with even minor friction or pressure. Baby John’s case illustrates the measurable impact: when his father reached out in desperation over a massive wound extending from his infant son’s ribs to his toes, donor-funded supplies of specialized ointments and bandages saved the child’s leg and life.
While immediate relief addresses urgent suffering, the organization’s Fast Cure Plan targets long-term solutions through a Multi-Pronged research strategy. The plan includes systemic research designed to treat the entire body rather than surface symptoms alone, gene therapy to override mutated skin proteins responsible for the fragile skin bond, and molecular research utilizing affordable natural ingredients to reduce inflammation and accelerate healing.
The expanded campaign invites compassionate donors and partners to become Hero Guardian Angels through a recurring monthly donor program starting as low as $3 per month. This expansion depends on a growing community of supporters who provide sustained funding for both immediate relief and accelerated research. Monthly contributions help ensure that children receive severe pain medicine, life-saving bandages, antibiotics, and therapeutic nutrition while simultaneously advancing cure research. Donor participation functions as guardianship, protecting vulnerable children until a full-body cure becomes reality.
Affordability stands as a core principle since any effective cure must remain accessible to all 500,000 EB sufferers globally, not exclusively to wealthy populations in developed nations. The research team brings expertise in genetic skin therapy and treatment approaches to this mission.
Scientific validation for the organization’s work appears in the National Institutes of Health peer-reviewed medical literature database. PMC article PMC10921121, co-authored by Dr. Tabor, directly addresses Epidermolysis Bullosa awareness and cure research. These and other publications establish that donor-funded interventions produce measurable outcomes, addressing concerns about effectiveness and grounding the campaign in scientific documentation. The team at No Baby Blisters explains that contributions enable pain-stopping, life-saving work for children who would otherwise remain medically neglected.
Interested supporters can contact the organization by phone at 469-431-2343 or access details about the campaign expansion at https://nobabyblisters.org/
No Baby Blisters
731 Chapel Hills Drive
Colorado Springs
Colorado
80920
United States
